Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
glucosamine + chondroitin sulfate + chloroquine
- Development stage
- Unknown
- Lead developer
- Pierre Fabre
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
A combination of glucosamine, chondroitin sulfate, and chloroquine. Glucosamine and chondroitin sulfate are commonly used together as dietary supplements for osteoarthritis to reduce joint pain and improve function. Glucosamine acts as a mild anti-inflammatory and is used by joints to make cartilage components. Chondroitin inhibits destruction and promotes production of cartilage components. Chloroquine is an antimalarial drug that has established roles in treating autoimmune conditions like SLE, RA, and osteoarthritis.
02
Targets
V-ATPase (Vacuolar-type H+-ATPase)
Beyond the preview
Go deeper on glucosamine + chondroitin sulfate + chloroquine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on glucosamine + chondroitin sulfate + chloroquine.